Shapiro, Rebecca S

Published purpose

The CIHR Institute of Infection and Immunity (CIHR-III) will fund applications that are determined to be specifically relevant to its mandate and its 2021-2026 Strategic Plan, with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases. This Priority Announcement will prioritize funding for research in the following research areas: • Infection: o Zoonotic or vector-borne transmission of pathogens in the context of Global Climate Change; o Understanding functional genomics and/or molecular epidemiology of emerging/re-emerging pathogens; o Resistance to fungal infections and/or the role of bacteriophages in combatting antimicrobial resistance (AMR). • Immunity: o Immune mechanisms involved in the development of trained innate immunity; o Immune mechanisms involved in the development and maintenance of tissue-specific immunity; o Metabolic regulation of immune cells and processes (immunometabolism). Should there be no eligible applications relevant to the research areas identified above, III will fund applications that are relevant to its mandate and its 2021-2026 Strategic Plan, with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases.